STUDY OF CEREBROTROPIC DOSE-DEPENDENT EFFECT OF PYRIMIDINE DERIVATIVE UNDER PIR-9 CODE AGAINST THE BACKGROUND OF EXPERIMENTAL CEREBRAL ISCHEMIA IN RATS

Nowadays, the incidence of cerebrovascular disease is steadily increasing. Disorders of cerebral circulation contribute to the increase in the degree of mortality, disability, and incapacitation of the population. An extensive arsenal of drugs with cerebroprotective effects does not satisfy clinical specialists. In this connection, there is an obvious need for new compounds exhibiting cerebroprotropic properties, as well as those able of improving the prognosis of the course of ischemic genesis pathologies.

The aim of the article is to study the dose-dependent cerebrotropic effect of a pyrimidine derivative under PIR-9 code against the background of experimental cerebral ischemia in rats.

Materials and methods. The experiment was conducted on 140 male Wistar rats (m=170–190 g) divided into 7 equal groups. Pyrimidine derivative PIR – 9 (25, 50 and 100 mg/kg), Vinpocetine (3.2 mg/kg) and Cinnarizine (5.6 mg/kg) suspension of purified water and Tween-80 were used as the studied substances. Experimental cerebral ischemia was reproduced by irreversible occlusion of common carotid arteries (chloral hydrate anesthesia – 350 mg/kg). Experimental substances, reference preparations and purified water were administered prophylactically within 10 days before surgery. One day later the survival, neurological deficiency, behavioral activity, changes in cognitive-mnestic functions, as well as some indicators of brain energy exchange were evaluated.

Results. In an experimental study of the cerebrotropic effect of the substance under PIR-9 code (pyrimidine-4-(1H)-one derivative) in various dosages against the background of irreversible occlusion of the common carotid arteries, a decrease in neurological, behavioral, mnestic and cognitive defects has been established. Hereby, the best effect was observed against the background of the administration of the compound PIR-9 at the dose of 50 mg kg. In addition, the prophylactic administration of the test substance PIR-9 (50 mg/kg) has shown the improvement of the energy metabolism in the postischemic period.

Conclusion. In the course of the study it was established that the substance under the laboratory code PIR-9 exhibited the most pronounced cerebroprotective effect at the dose of 50 mg/ kg, which was not inferior in its strength to the reference drug Cinnarizine and exceeding Vinpocetine.

1. Gusev EI, Martynov MYu, Kamtchatnov PR. Ishemicheskij insul`t. Sovremennoe sostoyanie problemy` [Ischemic Stroke: Current Status]. Doktor.ru. 2013; 5(83):7–12. Russian.

2. Gusev EI, Skvortczova VI, Martynov MYu. Cerebral`ny`j insul`t: problemy` i resheniya [Cerebral stroke: problems and solutions]. Annals of the Russian academy of medical sciences. 2003; 11:44–48. Russian.

3. Roy-O’Reilly M, McCullough LD. Sex Differences in stroke: the contribution of coagulation. Exp neurol. 2014; 259:16–27. DOI:10.1016/j.expneurol.2014.02.011.

4. Siniscalchi A, Gallelli L, Malferrari G, Pirritano D, Serra R, Santangelo E, De Sarro G. Cerebral stroke injury: the role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol. 2014; 25(2):131–7. DOI: 10.1515/ jbcpp-2013-0121.

5. Jin R, Liu L, Zhang S, Nanda A, Li G. Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res. 2013;6(5):834–51. DOI: 10.1007/s12265-013-9508-6.

6. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8(4):355–69. DOI: 10.1016/S1474-4422(09)70025-0.

7. Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng Z.J, Flegal K, O’Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr., Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113(6):e85–151. DOI: 10.1161/CIRCULATIONAHA.105.171600.

8. Efimova OS, Slobodenyuk AV, Belkin AA, Pinchuk EA. E`pidemiologiya insul`tov: vedushhie faktory` riska i napravleniya profilaktik [Epidemiology of strokes: the leading risk factors and directions of prevention]. Ural medical journal. 2008;8:43–46. Russian.

9. Usova NN. Infarkt golovnogo mozga u lits molodogo vozrasta [Stroke at persons in young age]. Problemy zdorov’ya i ekologii. 2012;1(31):23–7. Russian.

10. Soultanov VS, Zarubina IV, Shabanov PD. Cerebroprotektorny`e i e`nergostabiliziruyushhie e`ffekty` poliprenol`nogo preparata roprena pri ishemii golovnogo mozga u kry`s [Сerebroprotective and energy stabilizing effects of polyprenol drug ropren in ischemia of the brain in rats]. Reviews on clinical pharmacology and drug therapy. 2010;8(3):31–47. Russian.

11. Gupta JK, Chaudhary A, Dudhe R, Varuna K, Sharma PK, Verma PK. A review on the synthesis and therapeutic potential of pyrimidine derivatives. International journal of pharmaceutical sciences and research. 2010;1(5):34–49. DOI: 10.13040/IJPSR.0975-8232.1(5).34–49.

12. Kodonidi IP. Molekulyarnoe konstruirovanie N-zameshhenny`xproizvodny`x 1,3-diazinona-4 [Molecular design of n-substituted 1,3-diazinone-4 derivatives]. Pharmacy. 2010;1:36–40. Russian.

13. Samotrueva MA, Tsibizova AA, Yasenyavskaya AL, Ozerov AA, Tyurenkov IN. Farmakologicheskaya aktivnost` proizvodny`kch pirimidinov [Pharmacological activity of pyrimidine derivatives]. Astrakhan Medical Journal. 2015;10(1):12–29. Russian.

14. Voronkov AV, Shabanova NB, Kodonidi IP, Shatalov IS. Cerebroprotective activity of new derivatives of pyrimidine-4-(1H)-one PIR-9 and PIR-10 in irreversible occlusion of the common carotid artery. Pharmacy & Pharmacology. 2018;6(2):167–181. DOI: https://doi.org/10.19163/2307-9266-2018-6-2-167-181.

15. Nazarova LYe, D`yakova IN. Vliyanie kisloty` ferulovoj na zonu nekroza, voznikayushhego v rezul`tate okklyuzii srednej mozgovoj arterii [Effects of ferulic acid on the necrosis area caused by the middle cerebral artery occlusion]. Medical Bulletin of Bashkortostan. 2011;3:133–135. Russian.

16. Voronkov AV, Shabanova NB, Pozdnyakov DI, Lugovoy IS, Kodonidi IP. Vliyanie novy`x proizvodny`x pirimidin-4(1n)-ona na psixoe`mocional`ny`j disbalans i nekotory`e narusheniya e`nergeticheskogo obmena u kry`s na fone ishemii golovnogo mozga [Influence of new derivative pirimidin-4(1h)-she on psychoemotional imbalance and some violations of power exchange at rats against the background of brain ischemia]. Modern problems of science and education. 2017;5. URL: http://science-education.ru/ru/article/view?id=26738. Russian.

17. Lugovoy IS, Kodonidi IP, Voronkov AV, Shabanova NB, Kodonidi MI. Celenapravlenny`j sintez n-peptidny`x proizvodny`x n-pirimidin-4(1N)-ona, obladayushhix cerebroprotektorny`mi svojstvami [Purposeful synthesis of n-peptide derivatives of pyrimidine-4 (1H)-on having cerebroprotective properties]. Health and Education Millennium. 2017;19(8):195–199. Russian.

18. Yamamoto M, Shima T, Uozumi T, Sogabe T, Yamada K, Kawasaki T. A possible role of lipid peroxidation in cellular damages caused by cerebral ischemia and the protective effect of alpha-tocopherol administration. Stroke. 1983;14(6):977–82.

19. Sernov LN, Gaczura VV. E`lementy` e`ksperimental`noj farmakologii. [Elements of experimental pharmacology]. Moscow. 2000: 351 р. Russian.

20. McGraw CP, Pashayan AG, Wendel OT. Cerebral infarction in the Mongolian gerbil exacerbated by phenoxybenzamine treatment. Stroke. 1976;7(5):485–8.

21. Gannushkina IV. Mozgovoe krovoobrashhenie pri razny`kch vidakch cirkulyatornoj gipoksii mozga [Cerebral circulation in different types of circulatory hypoxia of the brain]. Annals of the Russian academy of medical sciences. 2000;9:22–27. Russian.

22. Voronina TA, Ostrovskaya RU. Metodicheskie ukazaniya po izucheniyu nootropnoj aktivnosti farmakologicheskix veshhestv [Guidelines for the study of nootropic activity of pharmacological substances]. Guidelines for experimental (preclinical) study of new pharmacological substances. Moscow, 2005;308–320. Russian.

23. Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007;2(2):322–8. DOI: 10.1038/nprot.2007.44.

24. Sestakova N, Puzserova A, Kluknavsky M, Bernatova I. Determination of motor activity and anxiety-related behaviour in rodents: methodological aspects and role of nitric oxide. Interdiscip Toxicol. 2013;6(3):126–35. DOI: 10.2478/intox-2013-0020.

25. Bondarenko NA. Anxiety and the Problem of “Inattentive” Animals in Water Maze Tests. The Russian Journal of Cognitive Science. 2017;4(4):45–51.

26. Suprun EV. Korrekciya ronkolejkinom nevrologicheskix i kognitivny`x narushenij v usloviyax bilateral`noj okklyuzii obshhix sonny`x arterij u kry`s [Correction receptor antagonist for interleukin-1 of neurological and cognitive disorders in experimental ischemic stroke]. Ukrainian journal of Psychoneurology. 2011;19(1(66)):26–30. Russian.

27. Arslanbekova VA, Vercholyak DV, Kurkin DV, Bakulin DA, Atapina NV, Brel AK, Lisina SV. Cerebroprotektornaya aktivnost` proizvodnogo gidroksibenzojnoj kisloty soedineniya S-38 na modeli okklyuzii obshhikch sonnykch arterij u krys [Cerebroprotective activity of c-38 derivative hydroxybenzoic acid in rats with bilateral common carotid artery occlusion]. Bulletin of Volgograde State Medical University. 2017;4(64):54–57. Russian.

28. Atochin DN, Chernysheva GA, Smolyakova VI, Osipenko AN, Logvinov SV, Zhdankina AA, Sysolyatin SV, Kryukov YA, Anfinogenova Y, Plotnikova TM, Plotnikov MB. Neuroprotective effects of p-tyrosol after the global cerebral ischemia in rats.Phytomedicine. 2016;23(7):784–792. DOI: 10.1016/j.phymed.2016.03.015.

29. Gromova OA, Grishina TR, Sadin AV, Nikonov AA, Nazarenko OA, Zhidomorov NYu, Vaczuro AA, Borzunov MP. Vliyanie cinnarizina i alvitila na mozgovoj krovotok i vy`sshuyu nervnuyu deyatel`nost` pri xronicheskoj e`ksperimental`noj ishemii golovnogo mozga [Influence of Cinnarizine and alvitil on cerebral blood flow and higher nervous activity in chronic experimental cerebral ischemia]. Neuroscience and Behavioral Physiology. 2004;104(1):52–53. Russian.

30. Tyurenkov IN, Kurkin DV, Volotova EV, Litvinov AA, Bakulin DA. Vliyanie razlichnykch kompozicij fenibuta s organicheskimi kislotami na nevrologicheskij, kognitivny`j i povedencheskij deficit u kry`s pri fokal`noj ishemii golovnogo mozga [Effect of organic acid compositions of phenibut on neurological, cognitive and behavioral deficit in rats with focal ischemic brain damage ]. Siberian Medical Journal. 2012;8:61–3. Russian.

31. Zarubina IV, Shabanov PD. Noopept reduces the postischemic functional and metabolic disorders in the brain of rats with different sensitivity to hypoxia. Bulletin of Experimental Biology and Medicine. 2009;147(3): 339–44.

32. Tao J, Cui Y, DuanY, Zhang N, Wang C, Zhang F. Puerarin attenuates locomotor and cognitive deficits as well as hippocampal neuronal injury through the PI3K/Akt1/GSK-3β signaling pathway in an in vivo model of cerebral ischemia. Oncotarget. 2017;8(63):106283–106295. DOI: 10.18632/oncotarget.22290.

33. Jincai W, Tingfang D, Yongheng Z, Zhongmin L, Kaihua Z, Xiaohong L. Effects of vinpocetine and ozagrel on behavioral recovery of rats after global brain ischemia. J Clin Neurosci.. 2014;21(4):661–3. DOI: 10.1016/j.jocn.2013.07.039.

34. Bogomolova OA, Demidova MA. Vliyanie novykch proizvodnykch 3-oksipiridina na povedenie krys v teste «pripodnyatyj krestoobraznyj labirint» [Effects of new derivatives of 3-oxypiridin on behavior of rats in the elevated plus maze (epm) experiments]. Modern problems of science and education. 2015;6:147. URL: http://science-education.ru/ru/article/view?id=23344. Russian.

35. Wen T, Zhang X, Liang S, Li Z, Xing X, Liu W, Tao J. Electroacupuncture Ameliorates Cognitive Impairment and Spontaneous Low-Frequency Brain Activity in Rats with Ischemic Stroke. J Stroke Cerebrovasc Dis. 2018; 27(10):2596–2605. DOI: 10.1016/j.jstrokecerebrovasdis.2018.05.021

36. Voronkov AV, Abaev VT, Oganesyan ET, Pozdnyakov DI. Nekotory`e aspekty` cerebroprotektornoj aktivnosti 4-gidroksi-3, 5-di-tretbutia korichnoj kisloty` pri ishemicheskom povrezhdenii golovnogo mozga v e`ksperimente [Some aspects of cerebroprotective activity of 4-hydroxy-3,5-di-tretboutyle of cinnamic acid in ischemic damage of the brain in experiment]. Medical News North Caucasus. 2018;13(1.1):90–3. Russian.

37. Makarova LM, Prikhod’ko MA, Pogorelyi VE, Skachilova SYa, Mirzoyan RS. Vliyanie proizvodnogo glutaminovoj i apovinkaminovoj kislot na metabolism golovnogo mozga v postishemicheskom periode [Effect of a new derivative of glutamic and apovincaminic acids on brain metabolism in post-ischemic period]. Experimental and clinical pharmacology. 2014;77(2):12–15. Russian.